A Comparison: High Intense Periodic vs. Every Week Therapy in Children With Cerebral Palsy (ACHIEVE) (ACHIEVE)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ohio
-
Columbus, Ohio, United States, 43205
- Nationwide Children's Hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- 2 to 8 years of age at initiation of treatment
- a diagnosis of motor delay or CP in GMFCS levels 1-V
- ability to tolerate a 2 hour therapy session based on parent report and evaluating therapists.
Exclusion Criteria:
- uncontrollable seizures or any co-morbid condition that prevents full participation during treatment sessions
- participation in another daily treatment program in the last 6 months
- auditory or visual conditions that prevent full participation during treatment sessions
- Progressive neurological disorder with no potential for improvement.
- Recent surgery where physical therapy is contraindicated.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: Usual weekly
Usual weekly physical therapy is 1 hours of therapy one day per week for 40 weeks.
|
One-on-one physical therapy sessions (one therapist and one patient).
Principles of motor learning used include repetition, task-specificity, active practice, generalization of skills, errors, structured practice, and developmentally appropriate feedback with sufficient time to practice.
|
|
Experimental: High intensity periodic
High intensity periodic physical therapy is 2 hours of therapy 5 days a week for 2 weeks, followed by an 18 week break, followed by another bout of high intensity therapy for 2 hours of therapy every weekday for two 10-consecutive-weekdays, followed by another 18 week break from therapy.
|
One-on-one physical therapy sessions (one therapist and one patient).
Principles of motor learning used include repetition, task-specificity, active practice, generalization of skills, errors, structured practice, and developmentally appropriate feedback with sufficient time to practice.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Gross Motor Function Measure (GMFM)-88
Time Frame: Baseline (pre-treatment) and 9 months 12 months, and 18 months following initiation of treatment.
|
GMFM evaluates change in gross motor function over time or with intervention in children
|
Baseline (pre-treatment) and 9 months 12 months, and 18 months following initiation of treatment.
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Goal Attainment Scaling (GAS)
Time Frame: Baseline (pre-treatment) and 9 months 12 months, and 18 months following initiation of treatment.
|
GAS creates patient, family, and clinical anchors as the external criterion for improvement by establishing activity or participation goals that reflect what an individual, family, and clinician consider meaningful or relevant.The GAS method allows for goals to be defined at different levels of mastery and assigned numerical values for score calculation, similar to a Likert scale.
The scale will have 5 points representing different levels of mastery of the individual patient's goal.
A score of -2 represents baseline, -1 less change than expected, 0 for the expected level of change, and +1 and +2 for achievement of more change than expected.
To attempt to ensure ordinality, each level on the scale will be described and will reflect a single dimension of change that is measureable, achievable, and relevant
|
Baseline (pre-treatment) and 9 months 12 months, and 18 months following initiation of treatment.
|
|
Change in Bayley Scales of Infant Development III
Time Frame: Baseline (pre-treatment) and 9 months 12 months, and 18 months following initiation of treatment.
|
The Bayley Scales of Infant and Toddler Development-Third Edition is an individually administered test designed to assess developmental functioning of infants and toddlers.
The Bayley-III assesses development in five areas: cognitive, language, motor, social-emotional, and adaptive behavior.
|
Baseline (pre-treatment) and 9 months 12 months, and 18 months following initiation of treatment.
|
|
Change in Pediatric Evaluation and Disability Inventory (PEDI)
Time Frame: Baseline (pre-treatment) and 9 months 12 months, and 18 months following initiation of treatment.
|
Administered as a parent survey.
The PEDI is a descriptive measure of a child's current functional performance and can track changes over time.
The PEDI measures both capability and performance of functional activities in three content domains: self-care, mobility, and social function.It can be used as a comprehensive clinical assessment of key functional capabilities and performance in children between the ages of six months and seven years.
|
Baseline (pre-treatment) and 9 months 12 months, and 18 months following initiation of treatment.
|
Other Outcome Measures
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Pediatric Outcomes Questionnaire (PODCI)
Time Frame: Collected at 0, 4.5 and 9 months (during the treatment period)
|
Parent survey to assess patients under the age of 19 years for overall health, pain, and ability to participate in normal daily activities, as well as more vigorous activities typically associated with young people.
The target populations are children and adolescents ages 2-18 years with general health problems, specifically any problems related to bone and muscle conditions.
|
Collected at 0, 4.5 and 9 months (during the treatment period)
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 2016N0031
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.